[ad_1]
Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron.
[ad_2]
Source link
Lilly obesity-pill trial results find a warmer reception on Wall Street this time around
Related Posts
‘I feel shaken’: A man offered $50 to powerwash my patio. He would not take ‘no’ for an answer.
[ad_1] I wasn’t interested. I told him, “No thanks.” That didn’t work. [ad_2] Source link
Here’s where Trump’s tariffs stand after this week’s salvos
[ad_1] U.S. President Donald Trump made a range of moves with tariffs as this week came to an end. Here’s…
Beer sales have dropped off. Modelo and Corona parent’s stock dives to a 5-year low.
[ad_1] Shares of Constellation Brands, parent of Corona and Modelo beer, sank to a five-year low after a profit and…